Quantitation of amphotericin B with use of high-pressure liquid chromatography.

A chemical method for determination of concentrations of amphotericin B in serum and cerebrospinal fluid (CSF) is described. After extraction with methanol, the antibiotic was separated by reverse-phase, high-pressure liquid chromatography and quantitated by absorption at 405 nm. The lower limit of detection of this assay was 0.02 microng/ml. Relative standard deviations of less than 3.6% were noted for multiple determinations of sera containing 0.20 and 1.00 microng of amphotericin B/ml. No interfering peaks were found in extracts of serum or CSF from normal humans or in extracts of serum from patients treated with other drugs and antimicrobial agents, including 5-fluorocytosine. Comparison of the method with microbiological assays showed correlation coefficients of 0.90 and 0.83 for serum and CSF determinations, respectively. This chemical assay is very rapid (less than 30 min), sensitive, accurate, and specific and appears to be suitable for routine clinical use.

[1]  M. Schotz,et al.  Quantitation of Antibiotics Using High-Pressure Liquid Chromatography: Tetracycline , 1976, Antimicrobial Agents and Chemotherapy.

[2]  A. Forrey,et al.  Assay of flucytosine and furosemide by high-pressure liquid chromatography. , 1975, Journal of pharmaceutical sciences.

[3]  E. Block,et al.  Flucytosine and amphotericin B: hemodialysis effects on the plasma concentration and clearance. Studies in man. , 1974, Annals of internal medicine.

[4]  C. Schaffner,et al.  Separation of polyene antifungal antibiotics by high-speed liquid chromatography. , 1974, Journal of chromatography.

[5]  T. A. Jacob,et al.  Analysis of cefoxitin, cephalothin and their deacylated metabolites in human urine by high-performance liquid chromatography. , 1974, Journal of chromatography.

[6]  B. Mirkin,et al.  Ion-pair extraction and high-speed liquid chromatography of cephalothin and deacetylcephalothin in human serum and urine. , 1973, Drug metabolism and disposition: the biological fate of chemicals.

[7]  T. Platt,et al.  AMPHOTERICIN B AND NYSTATIN , 1972 .

[8]  B. T. Fields,et al.  Amphotericin B serum concentrations during therapy. , 1970, Applied microbiology.

[9]  J. Bates,et al.  Amphotericin B toxicity. A follow-up report of 53 patients. , 1969, Annals of internal medicine.

[10]  J. Bennett,et al.  A pharmacologic guide to the clinical use of amphotericin B. , 1969, The Journal of infectious diseases.

[11]  Atkinson Aj,et al.  Pharmacokinetics of intrathecally administered amphotericin B. , 1969 .

[12]  J. A. Mccay,et al.  Bioassay for hamycin and amphotericin B in serum and other biological fluids. , 1969, Applied microbiology.

[13]  D. E. Rogers,et al.  Treatment of disseminated mycotic infectioons. A new approach to amphotericin B therapy. , 1968, The American journal of medicine.

[14]  D. Alling,et al.  NEPHROTOXICITY OF AMPHOTERICIN B; EARLY AND LATE EFFECTS IN 81 PATIENTS. , 1964, Annals of internal medicine.

[15]  L. B. Page.  SYLLABUS OF LABORATORY EXAMINATIONS IN CLINICAL DIAGNOSIS , 1961 .

[16]  Louria Db.  Some aspects of the absorption, distribution, and excretion of amphotericin B in man. , 1958 .

[17]  M. Littman,et al.  Coccidioidomycosis and its treatment with amphotericin B. , 1958, The American journal of medicine.

[18]  C. A. Perry,et al.  A Syllabus of Laboratory Examinations in Clinical Diagnosis , 1951, The Indian Medical Gazette.